Clair Labs, developer of contactless Israeli patient monitoring technology, has announced the completion of a $9 million seed funding round, led by 10D, with the participation of SleepScore Ventures, Maniv Mobility and Vasuki. The funds raised will accelerate the recruitment process for the research and development center in Tel Aviv, and will be used to open a US office, which will primarily focus on providing customer support in North America and driving marketing and sales. Clair Labs was founded in 2018 by CEO Adi Berenson and CTO Dr. Ran Margolin (CTO), who were previously colleagues in the Apple product incubation group. Berenson was previously vice president of business development and marketing for developer of 3D sensor technology PrimeSense, which was acquired by Apple. Clair Labs develops remote patient monitoring systems based on proprietary technology to acquire medical-grade physiological signs without contacting the patient. “The idea for Claire Laboratories began with a vision of proactive preventive medicine, which requires health monitoring that integrates with our lives when we are healthy, before diseases develop,” said Berenson. “With the outbreak of the Covid-19 epidemic, we realized how effective this disease is. And seamless monitoring really is for care facilities, Also, as it deals with tremendous patient capacity and increasing disease rates.Continuous and continuous monitoring of the patient will ensure early detection of deterioration or troublesome infection.It will help reduce adverse events such as patients falling, pressure ulcers etc. In the future, contactless monitoring will enable remote supervision of Patients in the home hospital. Clair Labs technology enables continuous, around-the-clock monitoring of physiological signs, such as: heart rate, respiration, air flow, body temperature, SpO2 and more. The system also monitors behavioral indicators, including sleep patterns and distress, tracks changes in a patient’s posture and detects their intention to rise, among other things. The data is fed to smart learning algorithms which in turn produce accurate assessments and alerts. It does all this without disturbing the patient and without overburdening caregivers with an extra workload. The company’s prototypes are undergoing clinical trials at Tel Aviv (Ichilov) Sourasky Medical Center and at the Israeli Assuta Institute of Sleep Medicine. Later this year, the company is set to begin pilots with leading sleep centers and hospitals in the United States. Published by Globes, Israel business news – en.globes.co.il – June 20, 2021 © Copyright Globes Publisher Itonut (1983) Ltd. 2021
0 Comments